Login / Signup

Raynaud's phenomenon as an adverse event associated with Bruton tyrosine kinase inhibitor.

Dimitrios DeligeorgakisChristina Adamichou
Published in: Rheumatology (Oxford, England) (2024)
Keyphrases
  • adverse drug
  • emergency department